HUMA earnings date and last-quarter result: next report 2026-08-10, last quarter in line, P/E -1.09. Updated 2026-07-23.
Humacyte (HUMA) Research Hub
Humacyte (HUMA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.4006 USD (-7.99%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.09, market cap 0.11B. This hub links to the full technical, earnings and options research available for HUMA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.4006 USD (-7.99%) |
| 52-week range | 0.337 USD – 1.11 USD |
| Trend regime | Range |
| 14-day RSI | 37.8 (Bearish) |
| Trailing P/E | -1.09 |
| Market cap | 0.11B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for HUMA
Covered Call on HUMA: how it works, illustrative setup around the real 0.4006 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HUMA: how it works, illustrative setup around the real 0.4006 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HUMA: how it works, illustrative setup around the real 0.4006 USD price, max profit/loss, breakeven and when to use it. Educational.
HUMA technical analysis: range, last 0.4006 USD, RSI 37.8, 52w range 0.337 USD–1.11 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is HUMA in?
Humacyte (HUMA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HUMA in an uptrend or downtrend?
As of 2026-10-26, HUMA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HUMA's trailing P/E ratio?
HUMA's trailing P/E is -1.09, with a market cap of 0.11B. See the earnings research page for full valuation detail.
When does HUMA next report earnings?
HUMA is next scheduled to report earnings on 2026-08-10.